Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-cigarettes in older smokers at high risk for lung cancer
NCT05144542Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2022
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of nicotine inhaler in nicotine dependence, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Combustible Cigarettes Per Day at 27 weeks. Started Mar 2022; status: active, not recruiting.
02
Drugs
nicotine inhaler
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT05144542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05144542.